# Matralix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/matralix

- Industry: Software
- Headquarters: Singapore, Singapore
- Website: www.matralix.com
- Total disclosed funding: $2.4M
- Latest round: Series A (Jul 15, 2019)
- Investors on record: 3

## About

Based in Singapore, and founded in 2014 by Dr. Renuga Gopal (CEO) and Saif Khan, Matralix Pte. Ltd. is a nano – and – micro materials foundry that aims to develop a procedure that protects and delivers active ingredients in cosmetics, pharmaceuticals, agrochemicals, and food. The company’s customer base is spread over Singapore, US, and France.

The firm operates as an encapsulation-based software company that offers a variety of platforms and automated desktop factories to the encapsulation sector for the discovery, development, and manufacturing of novel (bio)pharmaceutical, cosmetic, culinary, and fine chemical goods. Furthermore, the company provides two matralix systems one is an automated desktop factory that is used to make lipid-based capsules and beads known as MAT-V1A and another is a MAT-MN-V1A system for research and development to pilot–scale manufacturing. The company develops the manufacturing system and then licensed it to big organizations for use in their lab.

## Funding rounds

- Series A, Jul 15, 2019, $2.4M — National Research Foundation, Small World Group, SEEDS Capital

## Investors

- National Research Foundation — Series A
- Small World Group (https://capitalatlas.ai/funds/small-world-group) — Series A
- SEEDS Capital (https://capitalatlas.ai/funds/seeds-capital) — Series A